Simplex Trading’s Skye Bioscience SKYE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-263
Closed -$1.46K – 10445
2026
Q2
$1.46K Sell
263
-25
-9% -$157 ﹤0.01% 8751
2026
Q1
$1.41K Buy
288
+263
+1,052% +$1.71K ﹤0.01% 8496
2025
Q4
$149 Sell
25
-3,138
-99% -$36.7K ﹤0.01% 8276
2025
Q3
$99K Buy
3,163
+2,975
+1,582% +$89.9K ﹤0.01% 5763
2025
Q2
$6K Buy
+188
New +$3.11K ﹤0.01% 7691
2024
Q4
– Sell
-63
Closed -$1K – 9827
2024
Q3
$1K Buy
+63
New +$2.83K ﹤0.01% 8313

Other funds holding SKYE

Simplex Trading's SKYE Position: Q3 2026 in Review

Simplex Trading sold out of Skye Bioscience (SKYE) in Q3 2026, closing a stake of 3,372 shares — an estimated $18.7K sold.

Simplex Trading first reported a position in SKYE in Q4 2024 and held it in 4 quarters. The position peaked at $18.7K in Q2 2026. 31 funds tracked by Wall St. Rank hold SKYE as of Q3 2026.

  • Simplex Trading reported no remaining Skye Bioscience position as of Q3 2026 after selling out during the quarter.
  • Simplex Trading sold 3,372 Skye Bioscience shares in Q3 2026, an estimated $18.7K.
  • Simplex Trading first reported a position in Skye Bioscience in Q4 2024 and held it in 4 quarters.
  • Simplex Trading's Skye Bioscience position peaked at $18.7K in Q2 2026.
  • 31 funds tracked by Wall St. Rank held Skye Bioscience as of Q3 2026.

Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.